dc.creatorSvetaz, Laura Andrea
dc.creatorAgüero, María Belén
dc.creatorAlvarez, Sandra
dc.creatorLuna, Lorena Celina
dc.creatorFeresin, Gabriela Egly
dc.creatorDerita, Marcos Gabriel
dc.creatorTapia, Alejandro
dc.creatorZacchino, Susana Alicia Stella
dc.date.accessioned2020-03-17T14:19:55Z
dc.date.accessioned2022-10-15T06:22:18Z
dc.date.available2020-03-17T14:19:55Z
dc.date.available2022-10-15T06:22:18Z
dc.date.created2020-03-17T14:19:55Z
dc.date.issued2007-08
dc.identifierSvetaz, Laura Andrea; Agüero, María Belén; Alvarez, Sandra; Luna, Lorena Celina; Feresin, Gabriela Egly; et al.; Antifungal activity of Zuccagnia punctata Cav.: Evidence for the mechanism of action; Georg Thieme Verlag Kg; Planta Medica; 73; 10; 8-2007; 1074-1080
dc.identifier0032-0943
dc.identifierhttp://hdl.handle.net/11336/99780
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4354753
dc.description.abstractPetroleum ether and dichloromethane extracts of fruits, aerial parts and exudate of Zuccagnia punctata Cav. (Fabaceae) showed moderate antifungal activities against the yeasts C. albicans, S. cerevisiae and C. neoformans (MICs: 62.5-250 μg/mL) and very strong antifungal activities against the dermatophytes M. gypseum, T. rubrum and T. mentagrophytes (MICs: 8-16 μg/mL) thus supporting the ethnopharmacological use of this plant. Antifungal activity-directed fractionation of active extracts by using bioautography led to the isolation of 2′,4′-dihydroxy-3′-methoxychalcone (1) and 2′,4′-dihydroxychalcone (2) as the compounds responsible for the antifungal activity. Second-order studies included MIC80, MIC 50 and MFC of both chalcones in an extended panel of clinical isolates of the most sensitive fungi, and also comprised a series of targeted assays. They showed that the most active chalcone 2 is fungicidal rather than fungistatic, does not disrupt the fungal membranes up to 4 x MFC and does not act by inhibiting the fungal cell wall. So, 2′,4′-dihydroxychalcone would act by a different mechanism of action than the antifungal drugs in current clinical use, such as amphotericin B, azoles or echinocandins, and thus appears to be very promising as a novel antifungal agent. © Georg Thieme Verlag KG Stuttgart.
dc.languageeng
dc.publisherGeorg Thieme Verlag Kg
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-981561.pdf
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1055/s-2007-981561
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectANTIFUNGAL
dc.subjectBIOAUTOGRAPHY
dc.subjectCHALCONES
dc.subjectDENSITOMETRY
dc.subjectFABACEAE
dc.subjectMECHANISM OF ACTION
dc.subjectZUCCAGNIA PUNCTATA
dc.titleAntifungal activity of Zuccagnia punctata Cav.: Evidence for the mechanism of action
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución